Загрузка...
Chromatin remodeling is required for gene reactivation after Decitabine-mediated DNA hypomethylation
The DNA hypomethylating drug Decitabine (DAC) reactivates silenced gene expression in cancer and is approved for the treatment of the myelodysplastic syndrome. Gene reactivation after DAC is variable and incompletely understood. Here, we established a cell line system (YB5) derived from the SW48 col...
Сохранить в:
| Главные авторы: | , , , , , , , |
|---|---|
| Формат: | Artigo |
| Язык: | Inglês |
| Опубликовано: |
2010
|
| Предметы: | |
| Online-ссылка: | https://ncbi.nlm.nih.gov/pmc/articles/PMC2932851/ https://ncbi.nlm.nih.gov/pubmed/20713525 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1158/0008-5472.CAN-09-4474 |
| Метки: |
Добавить метку
Нет меток, Требуется 1-ая метка записи!
|